Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W1YM
|
|||
| Former ID |
DIB005888
|
|||
| Drug Name |
AS-1406
|
|||
| Synonyms |
Theranase; HuHMFG1-huRNase; Targeted apoptosis (RNase), Antisoma
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Antisoma plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Ribonuclease (RNase) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012949) | |||
| REF 2 | WO patent application no. 2005,0657,17, Liquid formulations of antibody conjugates. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.